139 related articles for article (PubMed ID: 1782327)
1. Anti-ligand antibodies as potential autoantigens: in vitro and in vivo characteristics of anti-bungarotoxin antibodies in the idiotype network.
Pachner AR; Itano AA; McCallum RM; Ricalton NS
Autoimmunity; 1991; 10(2):145-52. PubMed ID: 1782327
[TBL] [Abstract][Full Text] [Related]
2. Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes.
Souroujon MC; Barchan D; Fuchs S
Immunol Lett; 1985; 9(6):331-6. PubMed ID: 3874156
[TBL] [Abstract][Full Text] [Related]
3. Mapping of a cholinergic binding site by means of synthetic peptides, monoclonal antibodies, and alpha-bungarotoxin.
Conti-Tronconi BM; Tang F; Diethelm BM; Spencer SR; Reinhardt-Maelicke S; Maelicke A
Biochemistry; 1990 Jul; 29(26):6221-30. PubMed ID: 2207067
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal anti-acetylcholine receptor antibodies as probes for human acetylcholine-receptor in myasthenia gravis.
Vincent A; Whiting PJ; Heidenreich F; Roberts A
J Recept Res; 1988; 8(1-4):143-59. PubMed ID: 3260283
[TBL] [Abstract][Full Text] [Related]
5. Isolation of an antiidiotypic antibody with acetylcholine-receptor-like binding properties from myasthenia gravis patients.
Eng H; Lefvert AK
Ann Inst Pasteur Immunol; 1988; 139(5):569-80. PubMed ID: 3264701
[TBL] [Abstract][Full Text] [Related]
6. In vivo effects of neonatal administration of antiidiotype antibodies on experimental autoimmune myasthenia gravis.
Verschuuren JJ; Graus YM; Van Breda Vriesman PJ; Tzartos S; De Baets MH
Autoimmunity; 1991; 10(3):173-9. PubMed ID: 1756222
[TBL] [Abstract][Full Text] [Related]
7. Expression of human-Torpedo hybrid acetylcholine receptor (AChR) for analysing the subunit specificity of antibodies in sera from patients with myasthenia gravis (MG).
Loutrari H; Kokla A; Trakas N; Tzartos SJ
Clin Exp Immunol; 1997 Sep; 109(3):538-46. PubMed ID: 9328134
[TBL] [Abstract][Full Text] [Related]
8. Anti-idiotypic antibodies to anti-acetylcholine receptor antibody: characterization by ELISA and immunoprecipitation assays.
Pachner AR; Sourojon M; Fuchs S
J Neuroimmunol; 1986 Sep; 12(3):205-14. PubMed ID: 3488332
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanism.
Cleveland WL; Wassermann NH; Sarangarajan R; Penn AS; Erlanger BF
Nature; 1983 Sep 1-7; 305(5929):56-7. PubMed ID: 6604226
[TBL] [Abstract][Full Text] [Related]
10. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
Loutrari H; Tzartos SJ; Claudio T
Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal anti-idiotopic antibodies against myasthenia-inducing anti-acetylcholine receptor monoclonal antibodies. Preponderance of nonparatope-directed antibodies affecting antigen binding.
Agius MA; Geannopoulos CJ; Fairclough RH; Richman DP
J Immunol; 1988 Jan; 140(1):62-8. PubMed ID: 3257231
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
Whiting PJ; Vincent A; Newsom-Davis J
J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
[TBL] [Abstract][Full Text] [Related]
13. beta-Bungarotoxin binding protein is immunogenic but lacks myasthenogenicity in rats.
Qiao J; Wang ZY; Link H
J Neurol Sci; 1994 Feb; 121(2):190-3. PubMed ID: 8158214
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of the main immunogenic region of the Torpedo acetylcholine receptor.
Morell SW; Trinh VB; Gudipati E; Friend A; Page NA; Agius MA; Richman DP; Fairclough RH
Mol Immunol; 2014 Mar; 58(1):116-31. PubMed ID: 24333757
[TBL] [Abstract][Full Text] [Related]
15. Future therapeutic strategies in autoimmune myasthenia gravis.
Psaridi-Linardaki L; Mamalaki A; Tzartos SJ
Ann N Y Acad Sci; 2003 Sep; 998():539-48. PubMed ID: 14592926
[TBL] [Abstract][Full Text] [Related]
16. Anti-acetylcholine receptor antibodies block bungarotoxin binding to native human acetylcholine receptor on the surface of TE671 cells.
Pachner AR
Neurology; 1989 Aug; 39(8):1057-61. PubMed ID: 2761699
[TBL] [Abstract][Full Text] [Related]
17. Generation of acetylcholine receptor-specific human T cell lines using heterobifunctional antibody-targeted antigen presentation.
Wang D; Nicolle MW
J Neuroimmunol; 1999 Sep; 99(1):114-21. PubMed ID: 10496184
[TBL] [Abstract][Full Text] [Related]
18. Idiotypic network connectivity and a possible cause of myasthenia gravis.
Dwyer DS; Vakil M; Kearney JF
J Exp Med; 1986 Oct; 164(4):1310-8. PubMed ID: 2428915
[TBL] [Abstract][Full Text] [Related]
19. Receptor-like activity of a monoclonal anti-idiotypic antibody against an anti-acetylcholine receptor antibody.
Lefvert AK; Fulpius BW
Scand J Immunol; 1984 May; 19(5):485-9. PubMed ID: 6729408
[TBL] [Abstract][Full Text] [Related]
20. Role of the main immunogenic region of acetylcholine receptor in myasthenia gravis. An Fab monoclonal antibody protects against antigenic modulation by human sera.
Tzartos SJ; Sophianos D; Efthimiadis A
J Immunol; 1985 Apr; 134(4):2343-9. PubMed ID: 3973387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
